Torrent PharmaceuticalsConsolidated Quarterly Resultsin Rs. Cr.Mar'20Dec'19Mar'19Net Sales/Income from operations1,912.001,924.001,822.00Other Operating Income34.0042.0034.00Total Income From Operations1,946.001,966.001,856.00EXPENDITUREConsumption of Raw Materials331.00339.00360.00Purchase of Traded Goods279.00224.00144.00Increase/Decrease in Stocks-82.00-21.0029.00Power & Fuel------Employees Cost336.00354.00347.00Depreciation168.00163.00160.00Excise Duty------Admin. And Selling Expenses------R & D Expenses------Provisions And Contingencies------Exp. Capitalised------Other Expenses534.00530.00503.00P/L Before Other Inc., Int., Excpt. Items & Tax380.00377.00313.00Other Income15.0053.0017.00P/L Before Int., Excpt. Items & Tax395.00430.00330.00Interest102.00111.00123.00P/L Before Exceptional Items & Tax293.00319.00207.00Exceptional Items-----357.00P/L Before Tax293.00319.00-150.00Tax-21.0068.002.00P/L After Tax from Ordinary Activities314.00251.00-152.00Prior Year … [Read more...] about Torrent Pharma Consolidated March 2020 Net Sales at Rs 1,946.00 crore, up 4.85% Y-o-Y
Since the recently announced FDI hike is in defence manufacturing, it brings into focus India’s preparedness (or lack thereof) for efficient and seamless exports in strategic sectors. If the objective of this FDI hike is indeed to augment defence exports, then there is an emergent need to review the extant export control regulatory regime. India cannot afford to continue with its cautious, process driven approach if it truly wants to promote its defence exports and achieve the $5 billion target. … [Read more...] about It is India’s hour to shine, but will it?
Brokerages CLSA and HSBC see Patanjali Ayurved as the fastest growing FMCG company in India, though the company’s ambitions have been hurt by reckless expansion and inconsistent quality of products. Conducting clinical studies of a potential treatment for a deadly pandemic is an audacious move by the company. … [Read more...] about Baba Ramdev’s Patanjali says it has launched clinical trials to treat COVID-19